| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	Goldman Sachs analyst Scott Fidel maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from $2...
 
																	UBS analyst Kevin Caliendo maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from $180 to $170.
 
																	Cantor Fitzgerald analyst Sarah James maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from...
 
																	
 
																	
 
																	
 
																	Barclays analyst Andrew Mok downgrades Molina Healthcare (NYSE:MOH) from Equal-Weight to Underweight and lowers the price ta...
 
																	 
																	US healthcare insurance providers Centene and Oscar Health stocks are down after Molina Healthcare reported disappointing guida...